These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26789915)

  • 61. Ontogeny of human mucosal-associated invariant T cells and related T cell subsets.
    Ben Youssef G; Tourret M; Salou M; Ghazarian L; Houdouin V; Mondot S; Mburu Y; Lambert M; Azarnoush S; Diana JS; Virlouvet AL; Peuchmaur M; Schmitz T; Dalle JH; Lantz O; Biran V; Caillat-Zucman S
    J Exp Med; 2018 Feb; 215(2):459-479. PubMed ID: 29339446
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Understanding and modulating the MR1 metabolite antigen presentation pathway.
    McWilliam HEG; Salio M
    Mol Immunol; 2021 Jan; 129():121-126. PubMed ID: 33293099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence for MR1 antigen presentation to mucosal-associated invariant T cells.
    Huang S; Gilfillan S; Cella M; Miley MJ; Lantz O; Lybarger L; Fremont DH; Hansen TH
    J Biol Chem; 2005 Jun; 280(22):21183-93. PubMed ID: 15802267
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The burgeoning family of unconventional T cells.
    Godfrey DI; Uldrich AP; McCluskey J; Rossjohn J; Moody DB
    Nat Immunol; 2015 Nov; 16(11):1114-23. PubMed ID: 26482978
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells.
    Eckle SB; Corbett AJ; Keller AN; Chen Z; Godfrey DI; Liu L; Mak JY; Fairlie DP; Rossjohn J; McCluskey J
    J Biol Chem; 2015 Dec; 290(51):30204-11. PubMed ID: 26468291
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.
    Leeansyah E; Ganesh A; Quigley MF; Sönnerborg A; Andersson J; Hunt PW; Somsouk M; Deeks SG; Martin JN; Moll M; Shacklett BL; Sandberg JK
    Blood; 2013 Feb; 121(7):1124-35. PubMed ID: 23243281
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation and Function of iNKT and MAIT Cells.
    Chandra S; Kronenberg M
    Adv Immunol; 2015; 127():145-201. PubMed ID: 26073984
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Covering All the Bases: Complementary MR1 Antigen Presentation Pathways Sample Diverse Antigens and Intracellular Compartments.
    Kulicke C; Karamooz E; Lewinsohn D; Harriff M
    Front Immunol; 2020; 11():2034. PubMed ID: 32983150
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Editorial: Role of CD1- and MR1-Restricted T Cells in Immunity and Disease.
    Iwabuchi K; Van Kaer L
    Front Immunol; 2019; 10():1837. PubMed ID: 31447847
    [No Abstract]   [Full Text] [Related]  

  • 70. MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis.
    Gold MC; Napier RJ; Lewinsohn DM
    Immunol Rev; 2015 Mar; 264(1):154-66. PubMed ID: 25703558
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human mucosal-associated invariant T (MAIT) cells possess capacity for B cell help.
    Bennett MS; Trivedi S; Iyer AS; Hale JS; Leung DT
    J Leukoc Biol; 2017 Nov; 102(5):1261-1269. PubMed ID: 28807929
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Do T cells need endogenous peptides for activation?
    Gascoigne NR
    Nat Rev Immunol; 2008 Nov; 8(11):895-900. PubMed ID: 18846098
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modulation of Valpha19 NKT cell immune responses by alpha-mannosyl ceramide derivatives consisting of a series of modified sphingosines.
    Shimamura M; Huang YY; Okamoto N; Suzuki N; Yasuoka J; Morita K; Nishiyama A; Amano Y; Mishina T
    Eur J Immunol; 2007 Jul; 37(7):1836-44. PubMed ID: 17559170
    [TBL] [Abstract][Full Text] [Related]  

  • 74. From antigen presentation to T-cell activation.
    Lanzavecchia A
    Res Immunol; 1998; 149(7-8):626. PubMed ID: 9851512
    [No Abstract]   [Full Text] [Related]  

  • 75. MAIT cells and pathogen defense.
    Cowley SC
    Cell Mol Life Sci; 2014 Dec; 71(24):4831-40. PubMed ID: 25164578
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of major histocompatibility complex-related molecule 1 sequence variants in non-human primates.
    Ellis-Connell AL; Kannal NM; Balgeman AJ; O'Connor SL
    Immunogenetics; 2019 Feb; 71(2):109-121. PubMed ID: 30353260
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.
    Stone JD; Aggen DH; Chervin AS; Narayanan S; Schmitt TM; Greenberg PD; Kranz DM
    J Immunol; 2011 May; 186(9):5193-200. PubMed ID: 21451107
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression and trafficking of MR1.
    Lamichhane R; Ussher JE
    Immunology; 2017 Jul; 151(3):270-279. PubMed ID: 28419492
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.
    Tynan FE; Reid HH; Kjer-Nielsen L; Miles JJ; Wilce MC; Kostenko L; Borg NA; Williamson NA; Beddoe T; Purcell AW; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2007 Mar; 8(3):268-76. PubMed ID: 17259989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The CD8 isoform CD8alphaalpha is not a functional homologue of the TCR co-receptor CD8alphabeta.
    Gangadharan D; Cheroutre H
    Curr Opin Immunol; 2004 Jun; 16(3):264-70. PubMed ID: 15134773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.